Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 351 results for "mirati"

Mirati Therapeutics drops after patients treated with MGCD265 ...

News Editor Thinly traded Mirati Therapeutics (MRTX -17.2%) slumps on a 7x surge in volume in response to the presentation of an abstract (#2589) at ASCO on a Phase 1 trial of its tyrosine kinase inhibitor, MGCD265, in heavily pretreated patients ... Seeking Alpha, 1 month ago
Morning Market Losers Benzinga.com, 1 month ago
[x]  

9 images for mirati

Ticker Report, 2 weeks ago
Ticker Report, 1 month ago
American Banking News, 1 month ago
American Banking News, 4 months ago
Mideast Time, 4 months ago
KXXV-TV, 4 months ago
InsiderMonkey.com, 5 months ago
Nasdaq, 5 months ago
Pharmaceutical Business Review, 6 months ago

S-8 - Mirati Therapeutics, Inc. (0001576263) (Filer)

Document Format Files Seq Description Document Type Size 1 S-8 a15-13384_1s8.htm S-8 119786 2 EX-5.1 a15-13384_1ex5d1.htm EX-5.1 9361 3 EX-23.1 a15-13384_1ex23d1.htm EX-23.1 3046 4 EX-23.2 a15-13384_1ex23d2.htm EX-23.2 3444 Complete submission text ...
 SEC1 month ago
Ticker Report

Zacks Upgrades Mirati Therapeutics to Hold (MRTX)

Mirati Therapeutics (NASDAQ:MRTX) was upgraded by Zacks from a sell rating to a hold rating in a research report issued to clients and investors on Friday, MarketBeat reports. According to Zacks, Mirati Therapeutics, Inc. is a biopharmaceutical ...
 WKRB News3 weeks ago Mirati Therapeutics Rating Increased to Hold at Zacks (MRTX)  Ticker Report3 weeks ago Brean Downgrades Mirati Therapeutics To Hold  Benzinga.com1 month ago Notable Downgrades: Mirati Therapeutics (MRTX), Juniper (JNPR), Cloud Peak Energy (CLD), Paylocity Holding (PCTY)  Wall Street Pit1 month ago
[x]  

Mirati Therapeutics (MRTX) Shows Strength: Stock Up 7.2% - Tale of the Tape

Mirati Therapeutics, Inc. ( MRTX ) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend ...
 Yahoo! Finance2 months ago

Hamdan bin Zayed meets citizens miratis in Zayed City

Pictures Videos MADINAT ZAYED, Abu Dhabi, 22nd June 2015 (WAM) --- H.H. Sheikh Hamdan bin Zayed Al Nahyan, Ruler's Representative in the Western Region, today met with citizens at the majlis of the city. H.H. Sheikh Hamdan exchanged cordial ...
 WAM.ae1 month ago

Today's Morning Ratings: Templeton Dragon Fund, Inc. (TDF), Mirati Therapeutics, Inc. (MRTX), DreamWorks Animation SKG Inc. (DWA), Old Line Bancshares Inc. (OLBK), Nuveen Investment Quality Municipal Fund, Inc. (NQM)

WallStreet Scope Thursday July 30th: Templeton Dragon Fund, Inc. ( TDF ) from Singapore finished up on Wednesday with a weekly performance of -4.06% finishing the day at $22.69, gaining 0.04%. Shares traded at a volume of 104,769 shares and ...
 WallStreetScope.com22 hours ago Mirati Therapeutics Inc (MRTX) Drops 6.28% on July 29  Equities.com1 day ago Mirati Therapeutics Inc (MRTX) Jumps 6.19% on July 13  Equities.com2 weeks ago Mirati Therapeutics Inc (MRTX) is Trading Lower on Unusual Volume for June 01  Equities.com1 month ago

Coop: testa sconti mirati, nega perĂ² di proporre prezzi personali

Swissquote Bank Ltd ("Swissquote") is a bank licensed in Switzerland under the supervision of the Swiss Financial Market Supervisory Authority (FINMA). Swissquote is not authorized as a bank or broker by any US authority (such as the CFTC or SEC) ...
 Swissquote1 week ago
Ticker Report

Brokerages Set Mirati Therapeutics Target Price at $43.60 (NASDAQ:MRTX)

Mirati Therapeutics (NASDAQ:MRTX) has been given a consensus rating of Buy by the seven ratings firms that are currently covering the company, AnalystRatings.NET reports . Two investment analysts have rated the stock with a hold recommendation and ...
 SleekMoney2 weeks ago Mirati Therapeutics (MRTX) Analysts Recent Ratings Updates  WKRB News1 month ago Investment Analysts Weekly Ratings Updates for Mirati Therapeutics (MRTX)  Ticker Report1 month ago
Ticker Report

Mirati Therapeutics Receives Consensus Recommendation of Buy from Analysts (NASDAQ:MRTX)

Mirati Therapeutics (NASDAQ:MRTX) has received an average recommendation of Buy from the seven brokerages that are currently covering the company, Analyst Ratings.Net reports. Two analysts have rated the stock with a hold rating and five have ...
 Ticker Report2 weeks ago Mirati Therapeutics Given Average Recommendation of Buy by Brokerages (NASDAQ:MRTX)  WKRB News1 month ago Broker Upgrades and Downgrades & Key UK Corporate Snapshots 01 June 2015  DirectorsTalk1 month ago
Ticker Report

Zacks Lowers Mirati Therapeutics to Sell (MRTX)

Mirati Therapeutics (NASDAQ:MRTX) was downgraded by Zacks from a hold rating to a sell rating in a research note issued on Friday. According to Zacks, Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel ...
 Ticker Report1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less